Selecta Biosciences GAAP EPS of $0.08 beats by $0.19, revenue of $34M beats by $20.88M
- Selecta Biosciences press release (NASDAQ:SELB): Q1 GAAP EPS of $0.08 beats by $0.19.
- Revenue of $34M (+207.7% Y/Y) beats by $20.88M.
- SELB had $118.8 million in cash, cash equivalents, marketable securities, and restricted cash as of March 31, 2022, as compared to cash, cash equivalents, marketable securities, and restricted cash of $129.4 million as of December 31, 2021.